Experience

Meliora Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer

  • Sep 2021 - 2 years 4 months

  San Francisco Bay Area Developing the next generation of mechanism-focused oncology drugs.



Everest Detection

• Research
• 1 - 100 Employee

• Chief Business Officer

  • Jun 2018 - Dec 2021

  San Francisco Bay Area Our mission is to stage shift cancer to when it's curable - at its earliest stages. We aim to develop an early detection screening assay via liquid biopsy technologies.



Sheatree Capital

• Investor

  • Jul 2018 - 2021

  Sheatree Capital is a privately held investment fund which invests in innovative life science companies across multiple asset classes. Areas of interest include cancer immunotherapy, innovative oncology therapeutic platforms, neurodegenerative diseases, and more.



Benchling

• United States
• Software Development
• 700 & Above Employee

• Head of Commercial Operations

  • Aug 2015 - Mar 2018

  San Francisco First business hire at Benchling, a next generation enterprise software platform accelerating the pace of life science research. We are backed by Andreessen Horowitz, Thrive Capital, Benchmark, F-Prime, SV Angels, Founders Fund, Y Combinator and many others with over $300M in raised capital. Spearheaded scaling of commercial Go To Market org. Roles at Benchling included: first direct sales rep; establishing first product marketing, branding, and user acquisition initiatives; hiring &… Show more First business hire at Benchling, a next generation enterprise software platform accelerating the pace of life science research. We are backed by Andreessen Horowitz, Thrive Capital, Benchmark, F-Prime, SV Angels, Founders Fund, Y Combinator and many others with over $300M in raised capital. Spearheaded scaling of commercial Go To Market org. Roles at Benchling included: first direct sales rep; establishing first product marketing, branding, and user acquisition initiatives; hiring & leading technical sales team; hiring & managing enterprise sales reps; hiring sales VP's and directors; implementing sales systems (including CRM), playbooks, and performance metrics for sales and marketing; Led commercial partnership business development and strategic finance teams. Achieved top line growth >100% YoY every year at the company, establishing multi-million top line business from scratch, tripled logo count, and spurred head count company growth from 7 FTE to 80+. Personally drove customer acquisition of both premiere biopharma and cutting edge biotech clients including Genentech, Pfizer, Biogen, BMS, Editas Medicine, Voyager Tx, CRISPR Tx and others. Established and executed financing strategy resulting in multiple capital raises over the course of two years. Show less



KKR

• United States
• Financial Services
• 700 & Above Employee

• Private Equity

  • Jul 2014 - Aug 2015

  Greater New York City Area Invested in companies in logistics, infrastructure, and energy sectors, across both private and public markets from KKR's flagship North American PE fund. Completed investment in oil field services provider public company and assessed multiple up-stream, mid-stream and infrastructure private company investments. Spearheaded workstreams across complete cycle of investment process, from cultivating executive relationships, conducting competitive strategy deep dives, drafting and… Show more Invested in companies in logistics, infrastructure, and energy sectors, across both private and public markets from KKR's flagship North American PE fund. Completed investment in oil field services provider public company and assessed multiple up-stream, mid-stream and infrastructure private company investments. Spearheaded workstreams across complete cycle of investment process, from cultivating executive relationships, conducting competitive strategy deep dives, drafting and executing company diligence plans, implementing management 100 day plans and negotiating transaction terms. Additionally, liaised and managed third party advisors such as investment bankers, industry experts / consultants, accountants and legal counsel. Show less



Goldman Sachs

• United States
• Financial Services
• 700 & Above Employee

• Healthcare Investment Banking

  • May 2012 - Jul 2014

  Greater New York City Area Advised biopharma, biotech, and medical device corporate clients on M&A, strategic finance, and corporate matters, including $10bn+ of closed transactions. Select announced deals include Valeant / B&L; Pfizer / AstraZeneca anti-raid; Shire / NPS Pharma sell side. Led work flows related to merger and acquisition, capital raising and leveraged buyout advisory analysis, including company due diligence, memo preparation and financial valuation. Presented to management teams regarding… Show more Advised biopharma, biotech, and medical device corporate clients on M&A, strategic finance, and corporate matters, including $10bn+ of closed transactions. Select announced deals include Valeant / B&L; Pfizer / AstraZeneca anti-raid; Shire / NPS Pharma sell side. Led work flows related to merger and acquisition, capital raising and leveraged buyout advisory analysis, including company due diligence, memo preparation and financial valuation. Presented to management teams regarding industry trends, strategic positioning, potential M&A targets and corporate anti-raid strategies. Show less